ACTA1 and cancer: Recent reports have shown that interleukin-1 and TGF-β, which may be derived from cancer cells, can induce interleukin-6+ CAFs and αSMA+ CAFs in PDAC, respectively (Öhlund et al., 2017; Biffi et al., 2019).